PulseAGGREGATOR

Gathering headlines…

Pulse Aggregator

Your news command center for 10,000+ sources. Search, filter, and set alerts — then cut through the noise with bias analysis, story clustering, and blindspot detection.

PR Newswire

prCenter

1h ago

Aug 31, 2026, 06:45 ET Lilly to acquire Merida Biosciences to advance treatments for serious autoimmune and allergic diseases Merida's antibody-engineering platform is designed to enable precise, durable removal of disease-causing antibodies, while preserving normal immune function Initial Phase 1 data show MER511 achieved...translating…

Merida's antibody-engineering platform is designed to enable precise, durable removal of disease-causing antibodies, while preserving normal immune function Initial Phase 1 data show MER511 achieved...

Factuality

70/100

Political Bias

Center

Ownership

Cision

Country

USA

Region

North America

Language

English

Keywords#Initial Phase#MER511#Merida's#Aug#Biosciences

Read Original ↗ Article view

Comments

Loading comments…

Aug 31, 2026, 06:45 ET Lilly to acquire Merida Biosciences to advance treatments for serious autoimmune and allergic diseases Merida's antibody-engineering platform is designed to enable precise, durable removal of disease-causing antibodies, while preserving normal immune function Initial Phase 1 data show MER511 achieved... | Pulse Aggregator